Tetrakis(3-(2-bicyclo[2.2.1]heptanyl)-1,1,1-trifluoro-2-methylpropan-2-ol);2-(2-bicyclo[2.2.1]heptanyl)-1,1,1-trifluoropropan-2-ol;[2-[(5,5-dioxo-4-oxa-5λ6-thiatricyclo[4.2.1.03,7]nonan-2-yl)oxy]-2-oxoethyl] 2-oxopropanoate;ethyl 2-methylprop-2-enoate;tris(methyl 2-methylprop-2-enoate);methyl prop-2-enoate;[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-1-yl] 2-methylprop-2-enoate;[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)cyclohexyl] 2-methylprop-2-enoate
C121H181F21O29S — CID 162102738
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tetrakis(3-(2-bicyclo[2.2.1]heptanyl)-1,1,1-trifluoro-2-methylpropan-2-ol);2-(2-bicyclo[2.2.1]heptanyl)-1,1,1-trifluoropropan-2-ol;[2-[(5,5-dioxo-4-oxa-5λ6-thiatricyclo[4.2.1.03,7]nonan-2-yl)oxy]-2-oxoethyl] 2-oxopropanoate;ethyl 2-methylprop-2-enoate;tris(methyl 2-methylprop-2-enoate);methyl prop-2-enoate;[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-1-yl] 2-methylprop-2-enoate;[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)cyclohexyl] 2-methylprop-2-enoate
Tetrakis(3-(2-bicyclo[2.2.1]heptanyl)-1,1,1-trifluoro-2-methylpropan-2-ol);2-(2-bicyclo[2.2.1]heptanyl)-1,1,1-trifluoropropan-2-ol;[2-[(5,5-dioxo-4-oxa-5λ6-thiatricyclo[4.2.1.03,7]nonan-2-yl)oxy]-2-oxoethyl] 2-oxopropanoate;ethyl 2-methylprop-2-enoate;tris(methyl 2-methylprop-2-enoate);methyl prop-2-enoate;[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-1-yl] 2-methylprop-2-enoate;[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)cyclohexyl] 2-methylprop-2-enoate (PubChem CID 162102738) has the molecular formula C121H181F21O29S and a molecular weight of 2530.77 g/mol. Its IUPAC name is tetrakis(3-(2-bicyclo[2.2.1]heptanyl)-1,1,1-trifluoro-2-methylpropan-2-ol);2-(2-bicyclo[2.2.1]heptanyl)-1,1,1-trifluoropropan-2-ol;[2-[(5,5-dioxo-4-oxa-5λ6-thiatricyclo[4.2.1.03,7]nonan-2-yl)oxy]-2-oxoethyl] 2-oxopropanoate;ethyl 2-methylprop-2-enoate;tris(methyl 2-methylprop-2-enoate);methyl prop-2-enoate;[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-1-yl] 2-methylprop-2-enoate;[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)cyclohexyl] 2-methylprop-2-enoate.
Molecular Properties
| Compound Name | Tetrakis(3-(2-bicyclo[2.2.1]heptanyl)-1,1,1-trifluoro-2-methylpropan-2-ol);2-(2-bicyclo[2.2.1]heptanyl)-1,1,1-trifluoropropan-2-ol;[2-[(5,5-dioxo-4-oxa-5λ6-thiatricyclo[4.2.1.03,7]nonan-2-yl)oxy]-2-oxoethyl] 2-oxopropanoate;ethyl 2-methylprop-2-enoate;tris(methyl 2-methylprop-2-enoate);methyl prop-2-enoate;[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-1-yl] 2-methylprop-2-enoate;[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)cyclohexyl] 2-methylprop-2-enoate |
|---|---|
| PubChem CID | 162102738 |
| Molecular Formula | C121H181F21O29S |
| Molecular Weight | 2530.77 g/mol |
| Exact Mass | 2529.21 |
| IUPAC Name | tetrakis(3-(2-bicyclo[2.2.1]heptanyl)-1,1,1-trifluoro-2-methylpropan-2-ol);2-(2-bicyclo[2.2.1]heptanyl)-1,1,1-trifluoropropan-2-ol;[2-[(5,5-dioxo-4-oxa-5λ6-thiatricyclo[4.2.1.03,7]nonan-2-yl)oxy]-2-oxoethyl] 2-oxopropanoate;ethyl 2-methylprop-2-enoate;tris(methyl 2-methylprop-2-enoate);methyl prop-2-enoate;[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-1-yl] 2-methylprop-2-enoate;[4-(1,1,1-trifluoro-2-hydroxypropan-2-yl)cyclohexyl] 2-methylprop-2-enoate |
| SMILES | C=C(C)C(=O)OC.C=C(C)C(=O)OC.C=C(C)C(=O)OC.C=C(C)C(=O)OC1CCC(C(C)(O)C(F)(F)F)C2CCCCC12.C=C(C)C(=O)OC1CCC(C(C)(O)C(F)(F)F)CC1.C=C(C)C(=O)OCC.C=CC(=O)OC.CC(=O)C(=O)OCC(=O)OC1C2CC3C1OS(=O)(=O)C3C2.CC(O)(C1CC2CCC1C2)C(F)(F)F.CC(O)(CC1CC2CCC1C2)C(F)(F)F.CC(O)(CC1CC2CCC1C2)C(F)(F)F.CC(O)(CC1CC2CCC1C2)C(F)(F)F.CC(O)(CC1CC2CCC1C2)C(F)(F)F |
| InChI | InChI=1S/C17H25F3O3.C13H19F3O3.C12H14O8S.4C11H17F3O.C10H15F3O.C6H10O2.3C5H8O2.C4H6O2/c1-10(2)15(21)23-14-9-8-13(16(3,22)17(18,19)20)11-6-4-5-7-12(11)14;1-8(2)11(17)19-10-6-4-9(5-7-10)12(3,18)13(14,15)16;1-5(13)12(15)18-4-9(14)19-10-6-2-7-8(3-6)21(16,17)20-11(7)10;4*1-10(15,11(12,13)14)6-9-5-7-2-3-8(9)4-7;1-9(14,10(11,12)13)8-5-6-2-3-7(8)4-6;1-4-8-6(7)5(2)3;3*1-4(2)5(6)7-3;1-3-4(5)6-2/h11-14,22H,1,4-9H2,2-3H3;9-10,18H,1,4-7H2,2-3H3;6-8,10-11H,2-4H2,1H3;4*7-9,15H,2-6H2,1H3;6-8,14H,2-5H2,1H3;2,4H2,1,3H3;3*1H2,2-3H3;3H,1H2,2H3 |
| InChIKey | ZFCIQCCOGHPQKQ-UHFFFAOYSA-N |
| XLogP | 25.07 |
| TPSA | 438.75 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 172 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2530.77 |
| LogP ≤ 5 | 25.07 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 29 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162102738 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.